Literature DB >> 376135

Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.

D J Klaassen, D A Boyes, A Gerulath, M Levitt, A B Miller, J G Pearson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 376135

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

Authors:  A B Miller; D J Klaassen; D A Boyes; D J Dodds; A Gerulath; M E Kirk; M Levitt; J G Pearson; C Wall
Journal:  Can Med Assoc J       Date:  1980-09-06       Impact factor: 8.262

2.  Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.

Authors:  R H Earhart; J D Khandekar; D Faraggi; R A Schinella; T E Davis
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.